Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce the completion of a new 880-page report, “US Nucleic Acid Testing Market ” (http://www.vpgmarketresearch.com/us-natmarket.html). The report is designed to help current suppliers and potential market entrants identify and evaluate major opportunities emerging in the US nucleic acid testing market during this decade.
This report presents a comprehensive analysis of the US nucleic acid testing market, including:
•Comprehensive 880-page market segmentation analysis of the US NAT market.
•Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
•An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
•Ten-year test volume and reagent sales forecasts for the following categories:
– Infectious Diseases
– Cancer
– Forensic Testing
– Genetic Diseases
– Paternity Testing/HLA Typing
•Review of testing methodologies and instrumentation technologies.
•Feature comparison of automated and semiautomated analyzers.
•Sales and market shares of leading suppliers.
•Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
•Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
•Alternative market penetration strategies.
•Potential market entry barriers and risks.
•Business planning issues and concerns.
Contains 880 pages and 37 tables
To review or order this report, visit http://www.vpgmarketresearch.com/us-nat-market.html
Contact
Robert Fisher
Healthcare Research
[email protected]
+1 212 564 2838
http://www.VPGMarketResearch.com
